A patient with advanced head-and-neck cancer regained functional communication using an AI-generated voice clone after total glossectomy and laryngectomy.
Arrowhead’s small interfering RNA therapy reduced triglycerides and lowered pancreatitis risk in the phase 3 PALISADE trial, providing a quarterly self-administered option for patients with familial chylomicronemia syndrome.
At AMP 2025, Takunda Matose, PhD, urged pathologists to consider the limitations of big data and probabilistic reasoning to maximize AI’s benefits for clinical outcomes.
At AMP’s annual meeting, the organization also honored Alexis Carter, Dara Aisner, and Lawrence Jennings for their contributions to laboratory medicine and molecular pathology.
Researchers identify novel mechanism involving respiratory inhibition and oxidative stress that could overcome treatment challenges in nail infections.